{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:49:30Z","timestamp":1768038570985,"version":"3.49.0"},"reference-count":144,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.semnephrol.2014.09.006","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T21:45:58Z","timestamp":1418852758000},"page":"598-611","source":"Crossref","is-referenced-by-count":44,"title":["News on Biomarkers in CKD\u2010MBD"],"prefix":"10.1016","volume":"34","author":[{"given":"Sandro","family":"Mazzaferro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lida","family":"Tartaglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silverio","family":"Rotondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Bover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzia","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2014.09.006_bib1","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gft514","article-title":"Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?","author":"Cozzolino","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tem.2009.02.001","article-title":"Bone as an endocrine organ","volume":"20","author":"Fukumoto","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrrheum.2012.157","article-title":"The skeleton as an endocrine organ","volume":"8","author":"Digirolamo","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","article-title":"Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders","volume":"2","author":"Vervloet","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2310\/6650.2004.11824","article-title":"Biologic effects of parathyroid hormone metabolites: implications for renal bone disease","volume":"52","author":"Akhtar","year":"2004","journal-title":"J Investig Med"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2003-0024","article-title":"Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands","volume":"26","author":"Murray","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib9","doi-asserted-by":"crossref","first-page":"F975","DOI":"10.1152\/ajprenal.00336.2005","article-title":"PTH(1-84)\/PTH(7-84): a balance of power","volume":"290","author":"Friedman","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib10","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.clinbiochem.2012.04.029","article-title":"Acute and chronic regulation of circulating PTH: significance in health and in disease","volume":"45","author":"D\u05f3Amour","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/oxfordjournals.ndt.a027404","article-title":"Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study","volume":"11","author":"Coen","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2215\/CJN.09580911","article-title":"PTH--a particularly tricky hormone: why measure it at all in kidney patients?","volume":"8","author":"Garrett","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1359\/jbmr.2001.16.4.605","article-title":"Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function","volume":"16","author":"Gao","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2009.374","article-title":"Parathyroid hormone measurement in CKD","volume":"77","author":"Souberbielle","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib15","doi-asserted-by":"crossref","first-page":"e40242","DOI":"10.1371\/journal.pone.0040242","article-title":"Measuring parathyroid hormone (PTH) in patients with oxidative stress--do we need a fourth generation parathyroid hormone assay?","volume":"7","author":"Hocher","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib16","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1210\/jc.2013-2139","article-title":"Nonoxidized, biologically active parathyroid hormone determines mortality in hemodialysis patients","volume":"98","author":"Tepel","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000180876","article-title":"Is parathyroid hormone a uremic toxin?","volume":"19","author":"Massry","year":"1977","journal-title":"Nephron"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-139X.2009.00581.x","article-title":"Parathyroid hormone, a uremic toxin","volume":"22","author":"Rodriguez","year":"2009","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1525-139X.2008.00454.x","article-title":"Hypertrophy and fibrosis in the cardiomyopathy of uremia--beyond coronary heart disease","volume":"21","author":"Gross","year":"2008","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib20","first-page":"423","article-title":"The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification","volume":"74","author":"London","year":"2010","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib21","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/ki.2010.189","article-title":"Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals","volume":"117","author":"Kalantar-Zadeh","year":"2010","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0009-8981(90)90031-M","article-title":"The human alkaline phosphatases: what we know and what we don\u2019t know","volume":"186","author":"Harris","year":"1990","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib24","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bone.2009.07.009","article-title":"Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms","volume":"45","author":"Halling Linder","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib25","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/BF01951980","article-title":"Alkaline phosphatase binds to collagen; a hypothesis on the mechanism of extravesicular mineralization in epiphyseal cartilage","volume":"40","author":"Vittur","year":"1984","journal-title":"Experientia"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1749-6632.2010.05387.x","article-title":"Physiological role of alkaline phosphatase explored in hypophosphatasia","volume":"1192","author":"Whyte","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib27","doi-asserted-by":"crossref","first-page":"R1365","DOI":"10.1152\/ajpregu.2000.279.4.R1365","article-title":"Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1","volume":"279","author":"Johnson","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib28","doi-asserted-by":"crossref","first-page":"31171","DOI":"10.1074\/jbc.M102788200","article-title":"Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization","volume":"276","author":"Mornet","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib29","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00223-001-1137-4","article-title":"Differences in sialic acid residues among bone alkaline phosphatase isoforms: a physical, biochemical, and immunological characterization","volume":"71","author":"Magnusson","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1523-1755.2001.00794.x","article-title":"Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms","volume":"60","author":"Magnusson","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib31","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1093\/ndt\/gfp300","article-title":"Clinical significance of bone alkaline phosphatase isoforms, including the novel B1x isoform, in mild to moderate chronic kidney disease","volume":"24","author":"Haarhaus","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib32","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0272-6386(03)00197-5","article-title":"Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients","volume":"41","author":"Bervoets","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib33","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/ndt\/13.9.2294","article-title":"Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients","volume":"13","author":"Coen","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib34","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","article-title":"Circulating biochemical markers of bone remodeling in uremic patients","volume":"55","author":"Urena","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib35","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Urena","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ki.2012.77","article-title":"Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients","volume":"82","author":"Sardiwal","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2215\/CJN.04650512","article-title":"The case for routine parathyroid hormone monitoring","volume":"8","author":"Sprague","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib38","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/CIRCULATIONAHA.109.851873","article-title":"Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality","volume":"120","author":"Tonelli","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib39","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2215\/CJN.10091110","article-title":"Bone alkaline phosphatase and mortality in dialysis patients","volume":"6","author":"Drechsler","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib40","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.lfs.2011.11.006","article-title":"Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients","volume":"90","author":"Kobayashi","year":"2012","journal-title":"Life Sci"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib41","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1093\/ndt\/gft290","article-title":"Impact of age on survival predictability of bone turnover markers in hemodialysis patients","volume":"28","author":"Lertdumrongluk","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib42","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2215\/CJN.01910212","article-title":"Association of pre-kidney transplant markers of mineral and bone disorder with post-transplant outcomes","volume":"7","author":"Molnar","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib43","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ki.2008.26","article-title":"Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification","volume":"73","author":"Lomashvili","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1258\/000456306776865179","article-title":"The effect of alkaline phosphatase inhibitors on intracellular lipid accumulation in preadipocytes isolated from human mammary tissue","volume":"43","author":"Ali","year":"2006","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib45","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1053\/j.ajkd.2013.02.366","article-title":"Bone alkaline phosphatase in CKD-mineral bone disorder","volume":"62","author":"Sardiwal","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib46","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1210\/jc.2013-2024","article-title":"The relationship between glucose metabolism, metabolic syndrome, and bone-specific alkaline phosphatase: a structural equation modeling approach","volume":"98","author":"Cheung","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib47","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00223-009-9309-8","article-title":"Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme","volume":"85","author":"Janckila","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib48","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5414\/CNP71387","article-title":"Tartrate-resistant acid phosphatase isoform 5a as an inflammation marker in end-stage renal disease","volume":"71","author":"Janckila","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib49","doi-asserted-by":"crossref","first-page":"c103","DOI":"10.1159\/000081550","article-title":"How can we assess bone resorption in uremia?","volume":"98","author":"Mazzaferro","year":"2004","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib50","doi-asserted-by":"crossref","first-page":"14853","DOI":"10.1016\/S0021-9258(17)36541-9","article-title":"Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro","volume":"269","author":"Ek-Rylander","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib51","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1359\/JBMR.040603","article-title":"Intracellular machinery for matrix degradation in bone-resorbing osteoclasts","volume":"19","author":"Vaaraniemi","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib52","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00198-006-0286-8","article-title":"Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases","volume":"18","author":"Henriksen","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib53","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2008.03187.x","article-title":"Utility of serum tartrate-resistant acid phosphatase (TRAP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction","volume":"69","author":"Yamada","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib54","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bone.2003.04.002","article-title":"Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption","volume":"34","author":"Hannon","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib55","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0272-6386(03)00203-8","article-title":"Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis","volume":"41","author":"Chu","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib56","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00223-008-9127-4","article-title":"Serum levels of TRAP 5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients","volume":"82","author":"Shidara","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib57","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1359\/jbmr.080610","article-title":"Bone markers predict cardiovascular events in chronic kidney disease","volume":"23","author":"Fahrleitner-Pammer","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib58","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.2010121275","article-title":"Discriminants of prevalent fractures in chronic kidney disease","volume":"22","author":"Nickolas","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib59","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00223-007-9091-4","article-title":"Secreted tartrate-resistant acid phosphatase 5b is a marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model","volume":"82","author":"Rissanen","year":"2008","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib60","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","article-title":"Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards","volume":"22","author":"Vasikaran","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib61","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/ndt\/7.9.902","article-title":"Quantification of fetal antigen 2 (FA2) in supernatants of culture osteoblasts, normal human serum, and serum from patients with chronic renal failure","volume":"7","author":"Rasmussen","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib62","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1699-0463.1997.tb00583.x","article-title":"Serum concentration of the aminopropeptide of type I procollagen in patients on haemo- and peritoneal dialysis","volume":"105","author":"Jensen","year":"1997","journal-title":"APMIS"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib63","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.clinbiochem.2010.09.019","article-title":"Validation of an automated intact N-terminal propeptide of type I procollagen (PINP) assay","volume":"43","author":"Koivula","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib64","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1258\/acb.2009.009110","article-title":"Difference between total and intact assays for N-terminal propeptide of type I procollagen (PINP) reflects degradation of pN-collagen rather than denaturation of intact propeptide","volume":"47","author":"Koivula","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib65","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1258\/acb.2011.011040","article-title":"Comparison of total and intact aminoterminal propeptide of type I procollagen assays in patients with breast cancer with or without bone metastases","volume":"48","author":"Marin","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib66","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.clinbiochem.2012.03.023","article-title":"Measurement of amino terminal propetides of type I procollagen (PINP) in serum","volume":"45","author":"Koivula","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib67","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/ajkd.2002.35692","article-title":"Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients","volume":"40","author":"Ueda","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib68","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00774-003-0476-9","article-title":"Effect of hemodialysis and renal failure on serum biochemical markers of bone turnover","volume":"22","author":"Alvarez","year":"2004","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib69","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1359\/jbmr.2000.15.8.1526","article-title":"Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study","volume":"15","author":"Garnero","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib70","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s001980200068","article-title":"Biochemical indices of bone turnover and the assessment of fracture probability","volume":"13","author":"Johnell","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib71","first-page":"523","article-title":"Design of the Fracture Intervention Trial","volume":"13","author":"Black","year":"1993","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib72","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1359\/JBMR.040512","article-title":"Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial","volume":"19","author":"Bauer","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib73","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/sj.ki.5000311","article-title":"Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem","volume":"69","author":"Barreto","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib74","first-page":"52","article-title":"Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy","volume":"10","author":"Mazzaferro","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib75","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.3402\/fnr.v56i0.5329","article-title":"Vitamin K: the effect on health beyond coagulation-an overview","volume":"56","author":"Vermeer","year":"2012","journal-title":"Food Nutr Res"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib76","doi-asserted-by":"crossref","first-page":"18406","DOI":"10.1021\/ja207628k","article-title":"Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatitge crystals","volume":"133","author":"O\u2019Young","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib77","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.molmed.2012.12.008","article-title":"Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization","volume":"19","author":"Schrugers","year":"2013","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib78","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/386078a0","article-title":"Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein","volume":"386","author":"Luo","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib79","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.blre.2012.03.002","article-title":"Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists","volume":"26","author":"Chatrou","year":"2012","journal-title":"Blood Rev"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib80","doi-asserted-by":"crossref","first-page":"43052","DOI":"10.1074\/jbc.M407180200","article-title":"Processing and transport of matrix gammacarboxyglutamic acid protein and bone morphogenetic protein-2 in cultured human vascular smooth muscle cells: evidence for an uptake mechanism for serum fetuin","volume":"279","author":"Wajih","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib81","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.108.783738","article-title":"Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis","volume":"118","author":"Shroff","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib82","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","article-title":"Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD","volume":"15","author":"Reynolds","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib83","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIRCRESAHA.110.238808","article-title":"Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization","volume":"109","author":"Kapustin","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib84","doi-asserted-by":"crossref","first-page":"H523","DOI":"10.1152\/ajpheart.00826.2011","article-title":"Role of matrix Gla protein in angiotensin II-induced exacerbation of vascular calcification","volume":"303","author":"Jia","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib85","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.RES.87.11.1055","article-title":"Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies","volume":"8","author":"Proudfoot","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib86","doi-asserted-by":"crossref","first-page":"e35283","DOI":"10.1371\/journal.pone.0035283","article-title":"BMP-2 up-regulates PTEN expression and induces apoptosis of pulmonary artery smooth muscle cells under hypoxia","volume":"7","author":"Pi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib87","doi-asserted-by":"crossref","first-page":"18406","DOI":"10.1021\/ja207628k","article-title":"Matrix gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals","volume":"13","author":"O\u2019Young","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib88","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ki.2012.477","article-title":"Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease","volume":"83","author":"McCabe","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib89","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2215\/CJN.06420909","article-title":"Vitamins K and D status in stages 3-5 chronic kidney disease","volume":"5","author":"Holden","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib90","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1681\/ASN.2010040339","article-title":"Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD","volume":"22","author":"Schlieper","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib91","first-page":"648","article-title":"Warfarin: to use or not to use in chronic kidney disease patients?","volume":"23","author":"Cozzolino","year":"2010","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib92","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2011.10.041","article-title":"Effect of vitamin K(2) supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial","volume":"59","author":"Westenfeld","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib93","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/01.ATV.0000245793.83158.06","article-title":"Matrix Gla protein is associated with risk factors for atherosclerosis but not with coronary artery calcification","volume":"26","author":"O\u2019Donnell","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib94","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000099095","article-title":"Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis","volume":"27","author":"Mazzaferro","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib95","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cccn.2004.08.003","article-title":"Characteristics and performance of and immunosorbent assay for human matrix Gla-protein","volume":"351","author":"Schurgers","year":"2005","journal-title":"Clin. Chim Acta"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib96","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1159\/000124863","article-title":"The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification","volume":"45","author":"Cranenburg","year":"2008","journal-title":"J Vasc Res"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib97","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2215\/CJN.07081009","article-title":"The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report","volume":"5","author":"Schurgers","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib98","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ki.1985.198","article-title":"Bone GLA protein in predialysis chronic renal failure. Effects of 1,25(OH)2D3 administration in a long-term follow-up","volume":"28","author":"Coen","year":"1985","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib99","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ki.1984.230","article-title":"Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis","volume":"26","author":"Malluche","year":"1984","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.gene.2004.03.003","article-title":"Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor","volume":"335","author":"Wellendorph","year":"2004","journal-title":"Gene"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib101","first-page":"3258","article-title":"Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin","volume":"83","author":"Gundberg","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib102","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine regulation of energy metabolism by the skeleton","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib103","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jbmr.321","article-title":"The osteoblast: an insulin target cell controlling glucose homeostasis","volume":"26","author":"Clemens","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib104","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1083\/jcb.200809113","article-title":"The sympathetic tone mediates leptin\u05f3s inhibition of insulin secretion by modulating osteocalcin bioactivity","volume":"183","author":"Hinoi","year":"2008","journal-title":"J Cell Biol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/jc.2008-1455","article-title":"Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus","volume":"94","author":"Kanazawa","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib106","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1359\/jbmr.081234","article-title":"Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men","volume":"24","author":"Kindblom","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib107","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/ATVBAHA.110.204859","article-title":"Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome","volume":"30","author":"Saleem","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib108","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKLRANK signaling in osteoclastogenesis and bone disease","volume":"12","author":"Wada","year":"2006","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib109","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/71667","article-title":"Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis","volume":"24","author":"Hughes","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib110","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1210\/endo.142.4.8070","article-title":"Determination of three isoforms of the receptor activator of nuclear factor-kB ligand and their differential expression in bone and thymus","volume":"142","author":"Ikeda","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib111","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/ RANKL\/RANK system for bone and vascular disease","volume":"292","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2014.09.006_bib112","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar2165","article-title":"Biology of RANK, RANKL, and osteoprotegerin","volume":"9","author":"Boyce","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib113","first-page":"1047","article-title":"Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin","volume":"95","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib114","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/01.ATV.0000012303.37971.DA","article-title":"RANK ligand and osteoprotegerin. Paracrine regulators of bone metabolism and vascular function","volume":"22","author":"Schoppet","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib115","first-page":"497","article-title":"Role of OPG\/RANKL\/RANK axis on the vasculature","volume":"23","author":"Papadopouli","year":"2008","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib116","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib117","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ndt\/17.2.233","article-title":"Serum osteoprotegerin and renal osteodystrophy","volume":"17","author":"Coen","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib118","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/ajkd.2002.31409","article-title":"Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients","volume":"39","author":"Haas","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib119","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/07853890.2012.727019","article-title":"The role of osteoprotegerin in cardiovascular disease","volume":"45","author":"Montagnana","year":"2013","journal-title":"Ann Med"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib120","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1681\/ASN.2005030260","article-title":"Plasma osteoprotegerin is associated with mortality in hemodialysis patients","volume":"17","author":"Morena","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib121","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2215\/CJN.05450513","article-title":"Biomarkers of vascular calcification and mortality in patients with ESRD","volume":"9","author":"Scialla","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib122","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1093\/ndt\/gfn242","article-title":"Serum osteoprotegerin level, carotid femoral pulse wave velocity and cardiovascular survival in haemodialysis patients","volume":"23","author":"Speer","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib123","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1093\/ndt\/gfh263","article-title":"Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients","volume":"19","author":"Nitta","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib124","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000324225","article-title":"The SCPP gene family and the complexity of hard tissues in vertebrates","volume":"194","author":"Kawasaki","year":"2011","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/cbf.2841","article-title":"The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled","volume":"30","author":"Rowe","year":"2012","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib126","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/geno.2000.6235","article-title":"MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia","volume":"67","author":"Rowe","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib127","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1006\/bbrc.2000.4146","article-title":"Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin","volume":"280","author":"Fisher","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib128","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1210\/en.2007-1205","article-title":"Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (min-hibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP","volume":"149","author":"Martin","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib129","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00223-009-9313-z","article-title":"MEPE\u05f3s diverse effects on mineralization","volume":"86","author":"Boskey","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1530\/JOE-12-0143","article-title":"The importance of the SIBLING family of proteins on skeletal mineralisation and bone remodelling","volume":"214","author":"Staines","year":"2012","journal-title":"J Endocrinol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib131","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1210\/en.2009-0216","article-title":"Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator","volume":"150","author":"David","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib132","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1523-1755.2005.00389.x","article-title":"Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs)","volume":"68","author":"Ogbureke","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib133","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/labinvest.2008.114","article-title":"Recent advances in the renal-skeletal-gut axis that controls phosphate homeostasis","volume":"89","author":"Kiela","year":"2009","journal-title":"Lab Invest"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib134","doi-asserted-by":"crossref","first-page":"e42329","DOI":"10.1371\/journal.pone.0042329","article-title":"Protective roles of DMP1 in high phosphate homeostasis","volume":"7","author":"Rangiani","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib135","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease","volume":"45","author":"Pereira","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib136","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bone.2004.09.015","article-title":"Surface Plasmon Resonance (SPR) confirms MEPE binds to PHEX via the MEPE-ASARM-motif: a model for impaired mineralization in X-linked rickets (HYP)","volume":"36","author":"Rowe","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib137","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/joe.1.05989","article-title":"Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets","volume":"183","author":"Bresler","year":"2004","journal-title":"J Endocrinol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib138","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1359\/jbmr.080601","article-title":"MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite\u2014an inhibition regulated by PHEX cleavage of ASARM","volume":"23","author":"Addison","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib139","doi-asserted-by":"crossref","first-page":"F783","DOI":"10.1152\/ajprenal.00304.2010","article-title":"ASARM peptides: PHEX-dependent and independent regulation of serum phosphate","volume":"300","author":"David","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib140","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1681\/ASN.2008030315","article-title":"The phosphatonin matrix extracellular phosphoglycoprotein (MEPE) inhibits renal intestinal phosphate transport in vivo","volume":"19","author":"Marks","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib141","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1126\/science.165.3899.1264","article-title":"Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo","volume":"165","author":"Francis","year":"1969","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib142","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/jbmr.345","article-title":"Sclerostin is a locally acting regulator of late-osteoblast\/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism","volume":"26","author":"Atkins","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib143","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1615\/CritRevEukarGeneExpr.v22.i1.50","article-title":"Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway","volume":"22","author":"Rowe","year":"2012","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.semnephrol.2014.09.006_bib144","doi-asserted-by":"crossref","first-page":"e97326","DOI":"10.1371\/journal.pone.0097326","article-title":"PHEX mimetic (SPR4-peptide) corrects and improves HYP and wild type mice energy-metabolism","volume":"9","author":"Zelenchuk","year":"2014","journal-title":"PLoS One"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929514001466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929514001466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T15:01:03Z","timestamp":1650812463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929514001466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":144,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0270929514001466"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2014.09.006","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}